language-icon Old Web
English
Sign In
Acemap > Paper > Effective treatments are required for patients with diffuse large B‐cell lymphoma (DLBCL) with primary refractory disease

Effective treatments are required for patients with diffuse large B‐cell lymphoma (DLBCL) with primary refractory disease

2017 
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.